BBN (@BigBiteNow) profile picture

Bringing logical analysis/research to my investments. The greatest investment we'll ever make is time itself. So DYOR and always check everything yourself.

Earth
Joined November 2011
Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)Photo by BBN (@BigBiteNow)
Come on #THX let’s start getting this second mine built.
101
So one would rightly believe that #AVCT will release an RNS tomorrow educating us all on what Dual Payload Candidate AVA6207 is all about.
1
1
5
334
$NVDA -JENSEN HUANG: "I CREATED PROBLEMS FOR THE BOARD THAT I DEEPLY REGRET. I OWN MY MISTAKES COMPLETELY" JENSEN HUANG: SINCE MY DEPARTURE, I’VE SEEN AN OUTPOURING OF CALLS FROM EMPLOYEES, INVESTORS, BUSINESS PARTNERS, AND CUSTOMERS FOR ME TO RETURN AS CEO
35
49
15
409
71,437
Difficult read here for stocks, as bulls and bears have plenty of datapoints to build strong bias. The S&P has held up really well to date with good rotation, while the main performers of this 4yr cycle are getting killed. What I'm focusing on currently - This Cyclical bull market is stretched historically. Now 48 months since the last low, this generally predictive 4 yr cycle is in the outlier category. Only the 1982-1986 cyclical bull ran longer (59 months), and that ended with the 87 crash. A great comp for today is the 1994-1998 month 44 high that resulted in only a 3 month-20% shakeout before dot com went ballistic. Are we at a similar spot with AI? So this 5 month chop could be setting up for an overdue correction into its 4yr cycle low. Within the context of a secular bull market only, the prior 13 (back to 1940) cyclical drops, the average drop was 23.75%, with the range being 15.56 to 35.88%. 10 of these fell within 20%-29%. So what I'm looking right here - I think we're far too oversold and the weekly cycle is about to turn higher. And from that initial move, the Cyclical bull will announce its presence (by December). I also think over the next 4 months, we're going to see an over-stretch move develop. This allows for taking on some additional risk today on the stretched AI driven cycle narrative, while drawing a very clear line on where the Cyclical bear market has likely taken hold.
25
18
3
347
24,480
Silver has reached the $46 target area but is still early Cycle duration wise. Silver also takes a very long time to rebase. Avoid. Focus on gold, it's setting up for a very nice re-entry again in Dec.
To my long time silver friends, why Silver is more likely heading to $46 before turning bullish again. Silver blow-off moves take a lot of time to retrace and rebuild a base. And often the last weekly cycle from the blowoff phase has to be retraced, in this case to $46. From a trend perspective, this remains an intermediate time frame retracement from the January blow-off move. The arrows show the corresponding gold Cycle highs/low, which are in decline. And the next weekly cycle low is not due until the end of 2026. From past experience, Silver in a bull market offers one of the best opportunities to post significant portfolio gains. It's because when it goes into a parabolic advance, it's generally just one relentless and straight move up, allowing for good positions to sit tight in. But those parabolic moves are short-lived (6 to 12 months) and then it takes a long time for another such environment to build. I feel strongly that Silver will go through another such environment in the near future, but know that it's always a process.
23
9
1
303
25,055
5 MAJOR DISRUPTIONS IN JUST 6 DAYS 🇺🇸 Nov 17: NSA classified network DOWN 🏦 Nov 16: JPMorgan banking failure ✈️ Nov 16: United Airlines outage 🛑 Nov 13: FAA nationwide ground stop 🌐 Nov 12–13: Microsoft 365 outage No coordinated cyberattack confirmed.
108
257
76
1,106
150,473
I’ve started to build my gold positions up again. Large caps first. ETFs coming next. Silver still on standby. Happy to be a little early and average down if gold drops further.
Off the charts deficits being spent. For me gold is about when to buy and not if.
2
4
348
U.S. HOMEBUILDER CONFIDENCE HITS LOWEST LEVEL SINCE APRIL 2012 U.S. homebuilder sentiment plunged to 25 in November, missing the 29 consensus and falling from 29 in October, according to the NAHB. 🔸 Current sales: 28 vs. 34 previously 🔸 Future sales: 30 vs. 32 🔸 Buyer traffic: 16 vs. 18 🔸 46% of builders cut prices, a post-pandemic high. 🔸 68% offered sales incentives. Elevated mortgage rates, labor shortages and rising construction costs continue to pressure the U.S. housing market.
21
43
7
151
87,274
Crack spreads are free fall now. The next 2-3 inflation reports are going to be incredibly soft
18
39
3
316
16,847
What's unfolding in the US is a policy mistake. The Fed is tying itself in knots over a backward-looking CPI while oil prices are tumbling. The result is that real rates and the Dollar are going through the roof, even as the growth picture is weakening... robinjbrooks.substack.com/p/…
17
33
5
122
18,509
Will Warsh be able to get a grip of these FED speakers and their incessant meaningless guidance. Several rate increases before Spring 2027. They are smoking the good stuff.
FED'S MUSALEM: ECONOMY LIKELY NEEDS SEVERAL RATE INCREASES BEFORE SPRING 2027
1
404
Cracking update from #KZG today which supports my bullish stance. Everything is on track with “early” 2027 first production the goal. It deserves to be trading higher on that update alone. londonstockexchange.com/en/n…
#KZG was one such purchase yesterday. Absolutely loaded with positives attributes over the coming months. Fully carried to production in Q1/Q2 with 20% of production (plus all diamonds found). Long awaited 2A license received which finally opens up commercial quantities. $1.75m payment coming “shortly.” Up to $10m due from Hebei over the next 2-3 years with chance they settle at $9m before YE. 20% retained by the company. Directors recent buying at average 1.43p. I calculate that they will have a minimum of $1m in cash at YE. FY27 forecast overall overheads running at under $1m which is great. The only issue is the strained relationship with Tracarta which may be the reason for the selling. Distressed selling into a significant company making period is a fabulous set up. My opinion only.
3
408
🇪🇺 EUROPEAN STOCK OPTIMISM HITS HIGHEST LEVEL SINCE FEBRUARY, BOFA SURVEY SHOWS Bank of America reports that a net 67% of fund managers expect European equities to rise over the next 1–3 months, up from 44% in October. Investors forecast 5.92% gains over the next 12 months, with 50% citing earnings upgrades as the key catalyst. Switzerland (+30%) and Germany (+27%) are the most favored markets, while France (-60%) hits a record low. Industrials lead sector positioning, while autos (-47%) remain the most underweight.
11
21
8
134
102,548
Exciting times for #AVCT even in this current dreary market environment.
In 2 days #AVCT present AVA6207 its Next Generation pre|CISION dual payload PDC (peptide drug conjugate) at EORTC-NCI-AACR. This is significant. GLOBALLY - There are zero dual payload PDCs in clinical trials. - There are Zero dual payload PDCs which have cleared IND studies - Zero ATR inhibitors have been approved by the FDA Avacta are preparing AVA6207 for IND enabling studies Even the computer knows the context here. 'Avacta Therapeutics holds the most advanced publicly disclosed program with AVA6207, a third-generation pre|CISION® dual-payload PDC delivering a topoisomerase I inhibitor (TOP1i) and an ATR inhibitor (ATRi)' What do you think happens to tumours when you take the most potent TOP1i in it's class Exatecan, (a drug pharma failed to harness for decades) and then add an ATR Inhibitor to stop DNA repair? There are a long list of reasons Avacta will likely be the first company globally to have a dual payload PDC in clinical trials. The obvious one is that pharma have failed to harness Exatecan and its systemic toxicity. Avacta have cracked the safety and tolerability because of pre|CISION a delivery mechanism which pharma simply don't have. The stage is set, the strategy in play....do pioneering things with assets pharma can't harness and make them pay big. AVA6103 could be the largest revenue generating oncology drug when considering the total addressable market (TAM) potential of the 8 indications on the current trial. AVA6207 could be even more valuable and that is what is at stake here. 2 days and we learn which ATRI payload is being used and who the likely pharma owner of that asset is. 2+2=4 and has always been the case.
1
28
1,844
So much scaremongering going on across so many stocks. They can’t all be rubbish so perhaps something else is going on.
1
1
6
4,117
Some of these pullbacks are now looking ridiculous. MMS/shorters are perhaps overplaying their hands. Just added #STX at sub 3p.
394
December 25bps max looks baked in because they can’t help themselves. But keep this disinflationary pressure up and it’ll be the last.
BREAKING: Big disinflation news in America. The US average retail gasoline price has fallen this morning to a 8-month low ($3.7818 per gallon) as strong refining margins for diesel keep gasoline supply abundant just as demand seasonally drops (plus winter grade gasoline is cheaper to make).
474
BBN retweeted
Replying to @Dorisderwent
You’re asking the wrong question. #AVCT could sign a deal tomorrow if it chose to. They could literally pick up the phone to almost any large pharma tomorrow and sell AVA6103 for an upfront payment which would fund AVCT through to take out. That would be the worst possible thing to do for shareholder value in the medium term. The question is how is the progression of AVA6103 shaping the value of AVA6207 and other 2nd Generation preCISION deals? On AVA6000, the deal depended on the PFS (which is now known). Parties will be combing that data. Tweaking the Phase 2 design. It’s a complex business, despite what X would have you believe. preCISION’s ability to cut across and the ‘exclusivity’ discussion makes it even more complex if maximum value is to be obtained. A poor CEO strikes the deal the snowflakes celebrate to the rafters, only to realise (in 12 months) they just gave away half the value of the company.
3
3
31
2,148
#KZG was one such purchase yesterday. Absolutely loaded with positives attributes over the coming months. Fully carried to production in Q1/Q2 with 20% of production (plus all diamonds found). Long awaited 2A license received which finally opens up commercial quantities. $1.75m payment coming “shortly.” Up to $10m due from Hebei over the next 2-3 years with chance they settle at $9m before YE. 20% retained by the company. Directors recent buying at average 1.43p. I calculate that they will have a minimum of $1m in cash at YE. FY27 forecast overall overheads running at under $1m which is great. The only issue is the strained relationship with Tracarta which may be the reason for the selling. Distressed selling into a significant company making period is a fabulous set up. My opinion only.
Call me nuts if you like but I’ve started buying a few stocks today. The doom and gloom is intense right now and I may be early but I also know things can quickly change.
1
2
727
🚨Supertanker rates have fallen 64% in 5 weeks. Shipping crude from the Gulf of Oman to 🇨🇳 China peaked at 841 Worldscale points on 8 Oct and was down to 308 by 13 Nov, Baltic Exchange data shows. That’s still well above the 150 to 200 range of the spring. Gulf exports are back near pre-war levels, so Asia needs fewer long voyages from the US, West Africa and the North Sea. Arrow’s Delia He told Reuters the drop is an “exaggerated unwinding” of the risk premium.
9
27
5
112
12,919